Ep2/4 agonists
作者： Eugene Yuanjin Rui , Bruce Allen Lefker , Ganesh Prasanna , Kimberly O'keefe Cameron , Achim Hans-Peter Krauss
DOI:
关键词:
摘要: EP2/4 compounds having improved dual pharmacological activity are described. The uniqueness of using agonists resides in their ability to modify both uveoscleral outflow via the ciliary muscle and conventional trabecular meshwork Schlemm's canal all same treatment paradigm. can be employed for glaucoma ocular hypertension. Formula (I).
lens.org 参考文章(35)
Roger Petrus Gerebern Vandecruys, Pharmaceutical compositions comprising cyclodextrins ,(1998)
Ernest Ludwig Eliel, Samuel H. Wilen, Lewis N. Mander, Stereochemistry of Organic Compounds ,(1962)
A.B. Kharlamb, Further Studies on the Effect of Prostanoid EP4 Receptor Stimulation on Aqueous Humor Dynamics in Monkeys Investigative Ophthalmology & Visual Science. ,vol. 46, pp. 3669- 3669 ,(2005)
M. Holoboski, M. Posner, D.F. Woodward, A.B. Kharlamb, R.M. Burk, Ciliary Muscle Relaxation Does Not Explain the Profound Ocular Hypotension Produced by a Selective Prostanoid EP4 Receptor Agonist 3,7–Dithia PGE1 in Monkeys Investigative Ophthalmology & Visual Science. ,vol. 47, pp. 413- 413 ,(2006)
Piero del Soldato, Antithrombotic organic nitrates ,(1997)
Ursula Schlötzer-Schrehardt, Matthias Zenkel, Rolf M Nüsing, Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Investigative Ophthalmology & Visual Science. ,vol. 43, pp. 1475- 1487 ,(2002)
Verney L. Sallee, Louis Desantis, Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma ,(1993)
Peter G. M. Wuts, Theodora W. Greene, Protective groups in organic synthesis ,(1981)
Alfonso R. Gennaro, Joseph P. Remington, Remington's pharmaceutical sciences Published in <b>1975</b> in Easton Pa) by Mack. ,(1985)
Laszlo Z. Bito, Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma ,(1983)